Europe — EMA
Lenalidomide Mylan
Lenalidomide, the active ingredient in Lenalidomide Mylan, is an immunomodulatory agent presented as a tablet for oral use. It is used to treat certain blood cancers, including multiple myeloma, myelodysplastic syndrome…
Request sourcing
What is Lenalidomide?
Lenalidomide, the active ingredient in Lenalidomide Mylan, is an immunomodulatory agent presented as a tablet for oral use. It is used to treat certain blood cancers, including multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma, in adult patients.
GNH USA supplies Lenalidomide Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.
What is Lenalidomide used for?
Lenalidomide is indicated for hematologic malignancies that involve abnormal plasma or lymphoid cells.
- Multiple Myeloma: improves progression‑free survival and overall response in patients with relapsed or refractory disease. - Myelodysplastic Syndromes: reduces transfusion dependence and delays transformation to acute leukemia in patients with del(5q) cytogenetic abnormality. - Mantle Cell Lymphoma: contributes to disease control when
Product details
Related products
A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo
A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo
A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo
A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo